EUVIMEDEUVIMED entdecken
VergleichsstudieEvaluationsstudieOpen Access · CC BY 4.0

Microbiological diagnosis of pleural infections: a comparative evaluation of a novel syndromic real-time PCR panel

Øyvind Kommedal iD, Tomas Mikal Eagan, Øystein Fløtten, Truls Michael Leegaard, William Siljan, Hilde Fardal, Bjørnar Bø, Fredrik Grøvan, Kjersti Wik Larssen, Arne Kildahl-Andersen, Reidar Hjetland, Rune Tilseth und 3 weitere

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.03510-23 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Øyvind Kommedal und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: Real-Time Polymerase Chain Reaction, Bacteria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current microbial diagnostics for pleural infections are insufficient. Studies using 16S targeted next-generation sequencing report that only 10%–16% of bacteria present are cultured and that 50%–78% of pleural fluids containing relevant microbial DNA remain culture negative. As a rapid diagnostic alternative suitable for clinical laboratories, we wanted to explore a PCR-based approach. Based on the identification of key pathogens, we developed a syndromic PCR panel for community-acquired pleural infections (CAPIs). This was a pragmatic PCR panel, meaning that it was not designed for detecting all possibly involved bacterial species but for confirming the diagnosis of CAPI, and for detecting bacteria that might influence choice of antimicrobial treatment. We evaluated the PCR panel on 109 confirmed CAPIs previously characterized using culture and 16S targeted next-generation sequencing. The PCR secured the diagnosis of CAPI in 107/109 (98.2%) and detected all present pathogens in 69/109 (63.3%). Culture secured the diagnosis in 54/109 (49.5%) and detected all pathogens in 31/109 (28.4%). Corresponding results for 16S targeted next-generation sequencing were 109/109 (100%) and 98/109 (89.9%). For bacterial species included in the PCR panel, PCR had a sensitivity of 99.5% (184/185), culture of 21.6% (40/185), and 16S targeted next-generation sequencing of 92.4% (171/185). None of the bacterial species present not covered by the PCR panel were judged to impact antimicrobial therapy. A syndromic PCR panel represents a rapid and sensitive alternative to current diagnostic approaches for the microbiological diagnosis of CAPI. IMPORTANCE Pleural empyema is a severe infection with high mortality and increasing incidence. Long hospital admissions and long courses of antimicrobial treatment drive healthcare and ecological costs. Current methods for microbiological diagnostics of pleural infections are inadequate. Recent studies using 16S targeted next-generation sequencing as a reference standard find culture to recover only 10%–16% of bacteria present and that 50%–78% of samples containing relevant bacterial DNA remain culture negative. To confirm the diagnosis of pleural infection and define optimal antimicrobial therapy while limiting unnecessary use of broad-spectrum antibiotics, there is a need for rapid and sensitive diagnostic approaches. PCR is a rapid method well suited for clinical laboratories. In this paper we show that a novel syndromic PCR panel can secure the diagnosis of pleural infection and detect all bacteria relevant for choice of antimicrobial treatment with a high sensitivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Real-Time Polymerase Chain ReactionBacteriaHumansBacterial InfectionsMiddle AgedMaleDNA, BacterialFemaleCommunity-Acquired InfectionsAgedHigh-Throughput Nucleotide SequencingRNA, Ribosomal, 16SAdultPleural DiseasesSensitivity and SpecificityAged, 80 and over

Stichwörter der Autor:innen

Fusobacterium nucleatumStreptococcus intermediusdiagnosticspleural empyemapleural infectionsyndromic PCR

Substanzen

DNA, BacterialRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
  • Division of Medicine and Laboratory Sciences, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Akershus, Norway.
  • Department of Pulmonary Medicine, Akershus University Hospital, Lorenskog, Akershus, Norway.

ORCID-Profile: Øyvind Kommedal, Ruben Dyrhovden

Zitieren

APA

Kommedal, Ø., Eagan, T. M., Fløtten, Ø., Leegaard, T. M., Siljan, W., Fardal, H., Bø, B., Grøvan, F., Larssen, K. W., Kildahl-Andersen, A., Hjetland, R., Tilseth, R., Hareide, S. K. Ø., Tellevik, M., & Dyrhovden, R. (2024). Microbiological diagnosis of pleural infections: a comparative evaluation of a novel syndromic real-time PCR panel. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03510-23

Vancouver

Kommedal Ø, Eagan TM, Fløtten Ø, Leegaard TM, Siljan W, Fardal H, et al. Microbiological diagnosis of pleural infections: a comparative evaluation of a novel syndromic real-time PCR panel. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03510-23

BibTeX
@article{Kommedal2024,
  author = {Kommedal, Øyvind and Eagan, Tomas Mikal and Fløtten, Øystein and Leegaard, Truls Michael and Siljan, William and Fardal, Hilde and Bø, Bjørnar and Grøvan, Fredrik and Larssen, Kjersti Wik and Kildahl-Andersen, Arne and Hjetland, Reidar and Tilseth, Rune and Hareide, Sølvi Kristine Øyen and Tellevik, Marit and Dyrhovden, Ruben},
  title = {Microbiological diagnosis of pleural infections: a comparative evaluation of a novel syndromic real-time PCR panel},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.03510-23}
}
Kostenlos starten →